Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
Improvements in quality of life, health utility, cost, and return to work for lymphoma patients after chimeric antigen receptor T- cells therapy in a real-world setting
批准号:
456739
负责人:
Wong William Wai Lun
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-09-01 至 2022-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The development of chimeric antigen receptor T-cells, or CAR T-cells has transformed oncology treatment, offering the potential to cure certain end-stage cancers including lymphoma. Because of the expense of these CAR T-cell therapies, and the large numbe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards establishing accurate estimates of national chronic hepatitis B prevalence and undiagnosed proportion in Canada
-
批准号:488763
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2023
-
负责人:Wong William Wai Lun
-
依托单位:
Developing policy models for sexually transmitted and blood-borne infection: integrating best evidence of effectiveness, safety, cost, and patient preferences
-
批准号:499040
-
项目类别:Salary Programs
-
资助金额:$83.78万
-
财政年份:2023
-
负责人:Wong William Wai Lun
-
依托单位:
Evaluating the impact of direct-acting antiviral treatment access policy on chronic hepatitis C prevalence and the undiagnosed proportion
-
批准号:475136
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2022
-
负责人:Wong William Wai Lun
-
依托单位:
Estimating chronic hepatitis B prevalence and the undiagnosed proportion in Canada using health administrative data
-
批准号:453432
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2021
-
负责人:Wong William Wai Lun
-
依托单位:
Understanding the treatment benefits of chimeric antigen receptor T-cells for lymphoma: quality of life, health utility, cost, and return to work
-
批准号:438086
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2020
-
负责人:Wong William Wai Lun
-
依托单位:
Towards eliminating viral hepatitis - Addressing hepatitis B using a multidisciplinary approach
-
批准号:414585
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2019
-
负责人:Wong William Wai Lun
-
依托单位:
Understanding the treatment benefits of novel antiviral agents for hepatitis C: quality of life, health utility, cost, and return to work
-
批准号:346614
-
项目类别:Operating Grants
-
资助金额:$34.25万
-
财政年份:2016
-
负责人:Wong William Wai Lun
-
依托单位:
Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection
-
批准号:310025
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Wong William Wai Lun
-
依托单位:
海外基金